摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-methoxy-N-(3-(4-(3-(4-methoxyacridin-9-ylamino)propyl)piperazin-1-yl)propyl)acridin-9-amine | 1203472-85-8

中文名称
——
中文别名
——
英文名称
4-methoxy-N-(3-(4-(3-(4-methoxyacridin-9-ylamino)propyl)piperazin-1-yl)propyl)acridin-9-amine
英文别名
N,N-bis(4-methoxy-9-acridinyl)-1,4-bis(3-aminopropyl)piperazine;4-methoxy-N-[3-[4-[3-[(4-methoxyacridin-9-yl)amino]propyl]piperazin-1-yl]propyl]acridin-9-amine
4-methoxy-N-(3-(4-(3-(4-methoxyacridin-9-ylamino)propyl)piperazin-1-yl)propyl)acridin-9-amine化学式
CAS
1203472-85-8
化学式
C38H42N6O2
mdl
——
分子量
614.79
InChiKey
LQIMLAAVEFRASA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.3
  • 重原子数:
    46
  • 可旋转键数:
    12
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    74.8
  • 氢给体数:
    2
  • 氢受体数:
    8

反应信息

  • 作为产物:
    描述:
    1,4-双(3-氨基丙基)哌嗪4-methoxy-9-phenoxy-acridine 反应 0.5h, 以1.23 g的产率得到4-methoxy-N-(3-(4-(3-(4-methoxyacridin-9-ylamino)propyl)piperazin-1-yl)propyl)acridin-9-amine
    参考文献:
    名称:
    单体和二聚吖啶化合物的合成作为阿尔茨海默病和朊病毒病的潜在治疗剂
    摘要:
    从取代的 9-氯吖啶开始,制备了一系列奎纳克林和间隔二聚吖啶化合物。使用基于 FACS 分析的快速筛选系统探索了它们中断朊病毒和阿尔茨海默特异蛋白与 Ab 肽的蛋白质结合的能力。双吖啶比相应的单体表现出更高的活性。在这些衍生物中,Aβ-肽的 2,4-二甲氧基-6-硝基化合物 7h 和 PrP 的 2-甲氧基-6-硝基化合物 7f 获得了最好的结果。
    DOI:
    10.1002/ardp.200900065
点击查看最新优质反应信息

文献信息

  • Synthesis of Bis-acridine Derivatives Exhibiting Anticancer and Anti-inflammatory Activity
    作者:Sham M. Sondhi、Sandeep Kumar、Reshma Rani、Ajanta Chakraborty、Partha Roy
    DOI:10.1002/jhet.985
    日期:2013.3
    A series of bis‐acridine derivatives 3aj and 5aj have been synthesized by condensation of 9‐chloro‐2,4‐(un)substituted acridines (1ae) and 9‐isothiocyanato‐2,4‐(un)substituted acridines (4ae) with diamine 2a and 2b, respectively. These bis‐acridines were evaluated in vitro for activity against a panel of human cancer cell lines of lung (NCI H‐522), ovary (PA1), breast (T47D), colon (HCT‐15), and liver (HepG2). Several bis‐acridines were found to possess good anticancer activity against various cancer cell lines. Of these, compound 3h exhibited good anticancer activity against all cancer cell lines tested except liver (HepG2) cell line. In addition to this, these compounds were screened for anti‐inflammatory activity at a dose of 50 mg/kg p.o. Compound 3g exhibited 41% anti‐inflammatory activity, which is better than most commonly used standard drug ibuprofen, which showed 39% anti‐inflammatory (at 50 mg/kg p. o.) activity.
  • Synthesis of Monomeric and Dimeric Acridine Compounds as Potential Therapeutics in Alzheimer and Prion Diseases
    作者:René Csuk、Alexander Barthel、Christian Raschke、Ralph Kluge、Dieter Ströhl、Lothar Trieschmann、Gerald Böhm
    DOI:10.1002/ardp.200900065
    日期:2009.12
    spacered dimeric acridine compounds was prepared. Their ability to interrupt the protein association of prion‐ and Alzheimer‐specific proteins and Ab peptides was explored using a fast screening system based on FACS analysis. The bis‐acridines displayed a higher activity than the corresponding monomers. Among these derivatives, best results were obtained with the 2,4‐dimethoxy‐6‐nitro compound 7h for
    从取代的 9-氯吖啶开始,制备了一系列奎纳克林和间隔二聚吖啶化合物。使用基于 FACS 分析的快速筛选系统探索了它们中断朊病毒和阿尔茨海默特异蛋白与 Ab 肽的蛋白质结合的能力。双吖啶比相应的单体表现出更高的活性。在这些衍生物中,Aβ-肽的 2,4-二甲氧基-6-硝基化合物 7h 和 PrP 的 2-甲氧基-6-硝基化合物 7f 获得了最好的结果。
查看更多